Drug application
CAPITAL AND CODEINE (ACETAMINOPHEN, CODEINE PHOSPHATE)
Drugs@FDA ANDA 085883 · ACTAVIS MID ATLANTIC
Key facts
| Drug name | CAPITAL AND CODEINE |
|---|---|
| Active ingredients | ACETAMINOPHEN, CODEINE PHOSPHATE |
| Application type | ANDA |
| Application number | 085883 |
| Company | ACTAVIS MID ATLANTIC |
| Dosage forms | SUSPENSION, ORAL |
| Strength | 120MG/5ML;12MG/5ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Jan 8, 1979 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.